Items

High-risk patients account for 80% of post-surgery deaths

Large UK-wide study shows that high-risk patients account for nearly 80% of post-surgery deaths, highlighting the need for open conversations and more tailored care.

Date added: Wednesday, February 25, 2026

Drug that targets immune cells shows potential as new treatment for diabetic heart disease

Researchers from Queen Mary University of London have found that a medication originally developed for glycemic control can reverse serious heart damage — not by controlling blood sugar as originally intended, but by retraining the immune system to protect the heart from within.

Date added: Friday, February 27, 2026

Queen Mary researchers lead report on avoidable inequalities in cardiovascular disease burden and care

Researchers from the William Harvey Research Institute at Queen Mary University of London have led a major new report revealing the continuing and unequal burden of cardiovascular disease (CVD) across Europe.

Date added: Friday, May 22, 2026

New AI heart failure screening tool could save lives, cut hospital waiting lists and deliver major NHS cost savings

Scientists at Queen Mary University of London and Barts Health NHS Trust have been awarded £1.3m to develop the invention for use in the NHS.

Date added: Thursday, June 11, 2026

Dr Suzanne Eldridge shortlisted for top business award

The nomination signals the growing importance of high-value science-led innovation within British entrepreneurship.

Date added: Monday, June 1, 2026

Psychological support service shown to improve staff wellbeing and reduce stress

A new study has found that a psychological support service is helping staff at Barts Health NHS Trust feel better, cope better, and remain in their roles.

Date added: Monday, June 29, 2026

William Harvey Research Institute celebrates 40 years of research excellence

The William Harvey Research Institute (WHRI) at Queen Mary University of London marked its 40th anniversary with a two-day conference celebrating four decades of excellence in cardiovascular, endocrine and inflammation research, alongside its longstanding commitment to education and training the next generation of scientists and clinicians.

Date added: Tuesday, June 30, 2026

Professor Michelangelo Campanella awarded prestigious European Research Council funding to accelerate safer drug discovery

, Professor of Pharmacology and Director of Research at the William Harvey Research Institute, has been awarded a prestigious European Research Council (ERC) Proof of Concept Grant to accelerate the translation of his research into a technology that could improve the safety and efficiency of drug development.

Date added: Wednesday, July 1, 2026

Excess sodium in heart cells may help explain heart damage linked to kidney disease

New research from Queen Mary University of London has identified a potential mechanism linking chronic kidney disease with changes in the heart, pointing towards new ways of understanding and potentially treating cardiovascular complications associated with kidney disease.

Date added: Tuesday, August 18, 2026

When AI meets Phage Display: Accelerating the future for life-saving antibodies

Ahuva Nissim is Professor in Antibody and Therapeutic Engineering at William Harvey Research Institute, Queen Mary University of London. In this article, Professor Nissim explore the potential of AI-designed artificial phage and how they could help address antibiotic resistance while opening new avenues for drug discovery.

Date added: Thursday, August 20, 2026

Where body fat is stored may matter more than BMI for heart health

A study led by researchers at Queen Mary University of London has found that where fat is stored in the body may be a better indicator of heart health than body mass index (BMI) alone.

Date added: Tuesday, August 25, 2026

Queen Mary leads €4.8m European network exploring new approaches to treating inflammatory disease

Queen Mary University of London is leading a €4.8 million European research network investigating how the body naturally switches off inflammation, with the aim of developing new approaches to treating chronic inflammatory diseases.

Date added: Wednesday, September 9, 2026

Study investigates how wrist-worn devices could improve blood pressure monitoring

Researchers at Queen Mary University of London have investigated a new way of interpreting blood pressure readings from cuffless wrist-worn devices, which could eventually make monitoring high blood pressure easier and more accessible.

Date added: Tuesday, September 15, 2026

Queen Mary research behind potential new heart attack treatment shows promise in Phase 2 trial

Research originating at Queen Mary University of London’s William Harvey Research Institute (WHRI) has helped underpin a potential new treatment designed to protect the heart from inflammation-related damage following a severe heart attack.

Date added: Thursday, September 17, 2026

Non-invasive nerve stimulation shows potential for treating uncontrolled high blood pressure

A non-invasive technique that stimulates nerves through the ear has been shown to be safe, well tolerated and easy for patients with uncontrolled high blood pressure to use at home, according to a clinical trial led by researchers at Queen Mary University of London.

Date added: Monday, September 28, 2026

Queen Mary researchers identify new blood vessel cells linked to liver fibrosis

Researchers at Queen Mary University of London have identified new populations of blood vessel cells that could help predict which patients with liver disease are at greatest risk of developing liver fibrosis.

Date added: Thursday, October 8, 2026

Global main menu

Study at Queen Mary

Experience Queen Mary

Subjects

Research and Innovation

Research by faculties and centres

Collaborations and partnerships